In the BioHarmony Drug Report Database
Albendazole
Albenza (albendazole) is a small molecule pharmaceutical. Albendazole was first approved as Albenza on 1996-06-11. It is used to treat ancylostomiasis, clonorchiasis, echinococcosis, enterobiasis, and giardiasis amongst others in the USA.
Trade Name
|
Albenza |
---|---|
Common Name
|
albendazole |
ChEMBL ID
|
CHEMBL1483 |
Indication
|
ancylostomiasis, clonorchiasis, echinococcosis, enterobiasis, giardiasis, helminthiasis, hymenolepiasis, necatoriasis, neurocysticercosis, opisthorchiasis, toxocariasis, trichuriasis |
Drug Class
|
Anthelmintics (tibendazole type) |
Image (chem structure or protein)